Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide — sold in the UK as Mounjaro — is a dual peptide medicine delivered via a pre-filled KwikPen, injected once a week. Each pen contains four doses. It works by mimicking two gut hormones, GIP and GLP-1, to reduce appetite and slow gastric emptying. As a prescription-only medicine, a prescriber must assess your suitability before treatment begins. If you've been reading about the tirzepatide peptide pen and aren't sure how it actually works in practice, you're in the right place. Most people come to this question with a mix of curiosity and slight apprehension, wondering whether a weekly injection is as straightforward as it sounds. It is, and this page explains exactly why.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The word "peptide" describes the class of molecule tirzepatide belongs to. Peptides are short chains of amino acids that mimic or interact with proteins in the body; tirzepatide is a synthetic peptide engineered to bind to both the GIP receptor and the GLP-1 receptor simultaneously. That dual action is what makes it distinct from semaglutide, which targets only the GLP-1 pathway.
In practical terms, this means the Mounjaro KwikPen is delivering a molecule that speaks to two appetite-regulating systems at once. GIP and GLP-1 are both released naturally after eating; tirzepatide amplifies those signals, helping you feel full sooner and for longer, while also slowing the rate at which food leaves the stomach. The result, documented in SURMOUNT-1, published in the New England Journal of Medicine, was an average body-weight reduction of around 20–21% at the 15 mg dose over 72 weeks in adults with obesity.
If you want to understand the device before you begin, our guide to tirzepatide pens and how they work covers the pen's physical format in more depth. You take it out of the fridge, let it reach room temperature as directed in the Patient Information Leaflet, attach a needle, and inject. That's the full technical complexity of it. Further detail on what the tirzepatide pen contains and how it's packaged covers the pen's physical format in more depth.
Preparation is mostly about consistency. Picking the same rough time each week (many people anchor it to a weekend morning) makes the routine stick. The pen lives in the fridge between 2–8°C; check the Patient Information Leaflet for the exact room-temperature window, since that changes once the pen is out of the fridge and the leaflet carries the authoritative figure.
Before injecting, wash your hands. Clean the skin at your chosen site with an alcohol swab and let it dry completely, injecting through wet skin increases local irritation. Medical-grade alcohol swabs designed for this purpose are available separately if you need them. Attach a fresh needle each time; reusing a needle blunts the tip and raises infection risk.
The three licensed injection sites are the abdomen (at least a few centimetres from the navel), the front or outer thigh, and the upper arm. Rotate between sites and within sites week by week, the full injection technique guide explains how to map a rotation pattern that avoids the same spot twice in a row. Rotating matters more than most people realise; using one small patch repeatedly can cause the tissue underneath to harden, which affects absorption.
Press the pen firmly and steadily against the skin) no pinching needed for most adults, then press and hold the injection button until the click confirms the dose is complete. Hold for a further ten seconds before removing, to reduce leakage. The needle is covered automatically after use; place it directly into a sharps container rather than recapping, and dispose of the container via your local council's sharps scheme.
Treatment begins at 2.5 mg, a dose chosen to let the body adjust rather than to produce immediate weight loss. Your prescriber will review progress before any increase. The titration schedule (moving through 5 mg, 7.5 mg, 10 mg, 12.5 mg and up to 15 mg in steps) is set by the prescriber based on your tolerance and response. Nausea and digestive discomfort are most common in the days after a dose increase; they usually settle within one to two weeks. The Mounjaro injection overview covers what to do if side effects persist.
If you're weighing up what the treatment costs alongside how it works, the cost context page explains what legitimate private pricing typically includes. As the NHS tirzepatide medicines page notes, tirzepatide is a prescription-only medicine; the prescriber decides both the starting dose and when to move up.
Once the initial adjustment period passes, most people settle into a straightforward weekly routine. The pen arrives in your fridge, you inject on your chosen day, and the clinical review before each repeat order checks that the dose is still appropriate and that any side effects are being managed well.
A few practical points that often get missed: if you travel, the pen can be kept at room temperature for a limited window, always check the leaflet rather than guessing. Never share a pen with anyone else. If a dose is missed, the tirzepatide injection guidance explains the timing rules, though the final word always sits with your prescriber and the PIL. Bring a note of any side effects, your current weight, and any other medicines you've started since your last review; that information shapes the prescriber's decision at each repeat.
Our clinical team reviews every consultation personally, a real prescriber reads your record, not software. Questions between orders go to our aftercare team, available seven days a week. If you're ready to start the process, the next step is a free consultation with our prescribers via our weight-loss treatments page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.